Cite
Freue M, Kjaer M, Boni C, et al. Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen. Breast. 2000;9(1):9-16doi: 10.1054/brst.1999.0118.
Freue, M., Kjaer, M., Boni, C., Joliver, J., Jänicke, F., Willemse, P. H., Coombes, R. C., Van Belle, S., Pérez-Carrión, R., Zieschang, J., Ibarra de Palacios, P., & Rose, C. (2000). Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen. Breast (Edinburgh, Scotland), 9(1), 9-16. https://doi.org/10.1054/brst.1999.0118
Freue, M, et al. "Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen." Breast (Edinburgh, Scotland) vol. 9,1 (2000): 9-16. doi: https://doi.org/10.1054/brst.1999.0118
Freue M, Kjaer M, Boni C, Joliver J, Jänicke F, Willemse PH, Coombes RC, Van Belle S, Pérez-Carrión R, Zieschang J, Ibarra de Palacios P, Rose C. Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen. Breast. 2000 Feb;9(1):9-16. doi: 10.1054/brst.1999.0118. PMID: 14731578.
Copy
Download .nbib